Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11931453
Drug delivery device
granted -
US 11932633
KRas G12C inhibitors
granted -
US 11931337
Compound antioxidant preparation for reducing the number of somatic cells in a livestock animal and a preparation method and application thereof
granted -
US 11931399
Compositions and methods for dengue virus chimeric constructions in vaccines
granted -
US 11931463
All-in-one fixed-dose combination for treating Helicobacter pylori infection
granted -
US 11931421
Muscle targeting complexes and formulations for treating myotonic dystrophy
granted -
US 11931354
Formulations of oxabicycloheptanes and oxabicycloheptenes
granted -
US 11932856
RNA targeting of mutations via suppressor tRNAs and deaminases
granted -
US 11932726
Method of making releasable polymeric reagents
granted -
US 11932852
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 11932851
Exon skipping compositions for treating muscular dystrophy
granted -
US 11932695
Modified antibodies and related compounds, compositions and methods of use
granted -
US 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted -
US 11932688
Treatment for neoplastic diseases
granted -
WO 2024052517
USAGE MÉDICAL D'ANTICORPS ANTI-CCR8 ET PROGRAMME DE DOSAGE
granted -
KR 20240034693
이량체 조영제의 제조
granted -
US 11926830
Modulators of Complement Factor B
granted -
US 11926828
Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
granted -
US 11926824
miRNA biogenesis in exosomes for diagnosis and therapy
granted -
US 11926825
Compounds and methods for reducing ATXN2 expression
granted -
US 11925689
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 11925663
Methods of managing tumor flare in adoptive immunotherapy
granted -
US 11925649
Treatments for diabetic neuropathy
granted -
US 11925629
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.